Venturi Wealth Management LLC Buys 152 Shares of DaVita Inc. (NYSE:DVA)

Venturi Wealth Management LLC boosted its position in DaVita Inc. (NYSE:DVA) by 59.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 406 shares of the company’s stock after purchasing an additional 152 shares during the period. Venturi Wealth Management LLC’s holdings in DaVita were worth $61,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Transcendent Capital Group LLC acquired a new stake in DaVita in the 3rd quarter valued at about $25,000. Blue Trust Inc. lifted its stake in DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after purchasing an additional 119 shares during the last quarter. Quarry LP acquired a new stake in DaVita in the 3rd quarter valued at about $60,000. Versant Capital Management Inc lifted its stake in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Wingate Wealth Advisors Inc. acquired a new stake in DaVita in the 4th quarter valued at about $82,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Trading Down 0.3 %

Shares of DVA stock opened at $141.96 on Tuesday. The firm has a 50 day moving average price of $160.86 and a two-hundred day moving average price of $158.19. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market capitalization of $11.36 billion, a PE ratio of 13.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. DaVita Inc. has a 12-month low of $124.42 and a 12-month high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DVA shares. Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of “Hold” and a consensus price target of $162.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.